TGM2 and glioblastoma: Specifically in glioblastoma, TGM2 has been found to be preferentially expressed in mesenchymal subtype glioblastoma and its inhibition in a subset of glioblastoma cells reduces proliferation in cell culture and in a xenograft model [29, 30].